Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer.

Tomoko YoshihamaYuka KurodaTatsuyuki Chiyoda Mio Takahashi Takuma Yoshimura Keiko Saotome Yoshiko Nanki Kensuke Sakai Yusuke Kobayashi Wataru Yamagami Daisuke Aoki

Published in: International journal of clinical oncology (2022)

Olaparib maintenance therapy for platinum-sensitive recurrent ovarian cancer in the Japanese population is sufficiently safe and no less effective than reports from previous studies.

Keyphrases

papillary thyroid
acute lymphoblastic leukemia
acute myeloid leukemia
squamous cell
multiple myeloma
open label
case control
squamous cell carcinoma
randomized controlled trial
clinical trial
adverse drug
childhood cancer
electronic health record